Efficacy and Safety of Hemostatic Methods in Distal Radial Artery Approach for Cardiac Catheterization (HEMOSTAD-INC)

September 18, 2023 updated by: Arnoldo Enmanuel Loáisiga Sáenz, Instituto Nacional de Cardiologia Ignacio Chavez
Comparison of PreludeSYNC distal and Modified Terumo Radial Band in patients with distal radial approach.

Study Overview

Status

Active, not recruiting

Detailed Description

INTRODUCTION AND BACKGROUND

Distal radial access at the level of the anatomical snuffbox and dorsal region of the hand has currently positioned itself as a viable and safe approach for procedures in interventional cardiology, whether diagnostic, simple, or complex angioplasties. We know that this approach method mainly reduces the occlusion rate of the proximal radial artery, among other advantages; however, we still do not have scientific evidence on the various hemostasis methods for this approach. Practice varies between centers and countries and hemostasis methods vary from an elastic compression bandage to the use of devices manufactured specifically for this approach such as the PreludeSYNC DISTAL or modification of devices manufactured for proximal radial hemostasis such as the TR band. In this clinical trial, we intend to analyze the efficacy and safety of two hemostasis methods in patients who require an interventional procedure (PredludeSYNC DISTAL vs modified TR band), to date, there is no clinical trial that compares these methods face to-face in relation to their efficacy and safety. Retrospective studies indicate that both methods are effective in reducing radial artery occlusion and are safe in reducing the bleeding/hematoma rate.

THE PURPOSE OF THE STUDY To compare the efficacy (distal radial artery occlusion) and safety (hematoma/bleeding) of two devices of distal radial hemostasis (PreludeSYNC distal and TR band) in patients undergoing percutaneous coronary intervention.

STUDY DESIGN Experimental, randomized, prospective, longitudinal, prolective, and comparative.

SUBJECTS OF STUDY Patients from the Ignacio Chávez National Institute of Cardiology who will undergo distal radial percutaneous coronary intervention/angiography.

METHODOLOGY After signing the informed consent, patients will be randomized by balanced block methods to: 1) Hemostasis using the PreludeSYNC distal device, or 2) Hemostasis using the Modified Radial Band device.

PRIMARY OUTCOME To compare the efficacy (distal radial artery occlusion) and safety (hematoma/bleeding) of PreludeSYNC distal versus Modified Terumo Radial Band in distal radial approach.

Study Type

Interventional

Enrollment (Estimated)

482

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mexico City, Mexico, 14080
        • Instituto Nacional de Cardiología Ignacio Chavez

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Coronary artery disease including chronic coronary syndrome or acute coronary syndrome.
  • Cardiovascular disease that requires coronary angiography in its approach.

Exclusion Criteria:

  • Cardiogenic shock.
  • Lesions in venous or arterial hemoducts.
  • Impossibility to provide informed consent.
  • Chronic kidney disease on hemodialysis through arteriovenous fistula at the same site where the approach is planned.
  • Severe chronic renal failure (GFR less than 30 ml/min/m2)
  • Patients diagnosed with cancer.
  • Patient with rheumatological and hematological pro-thrombotic disorders.
  • Non-hydrophilic radial introducer.
  • Failed cannulation of the radial artery with an introducer.
  • Successful trans-radial access that is crossed over to the femoral approach.
  • Patients with an interventional procedure using a radial approach in the previous 30 days.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Modified Terumo Radial Band

A standard hemostatic device used for proximal radial approach. The hard plastic component is removed to achieve better attachment in the distal radial approach.

  • Clean and dry the puncture site.
  • The introducer is withdrawn 2 cm.
  • Place the device on the patient's hand depending on the approach side.
  • Terumo logo is positioned toward the little finger side.
  • The green mark is positioned 1 cm proximal to the puncture site.
  • The bands are adjusted and fixed around the wrist.
  • The Terumo syringe is filled with 15 ml of air.
  • The balloon of the device is slowly inflated through the valve while the introducer is slowly withdrawn simultaneously.
  • Once the introducer is completely withdrawn, the balloon continues to be inflated until the absence of bleeding is verified.
  • Once hemostasis is achieved, the patient must be able to move his fingers and wrist without bleeding. If bleeding is observed, the balloon is inflated to achieve adequate hemostasis.
Hemostasis after distal radial approach is done with one of two devices, one of them is designed specifically for the distal radial approach; the other is not but a modified technique with the last one could be helpful.
Other Names:
  • PreludeSYNC distal
  • Terumo Radial Band
Active Comparator: PreludeSYNC distal

A specific hemostatic device, designed for distal radial approach.

  • Clean and dry the puncture site.
  • Selection and preparation of the PreludeSYNC distal device according to the approach side.
  • The introducer is withdrawn 2cm.
  • The hemostasis device is placed on the patient's hand.
  • Bands position: 1) little finger side; 2) thumb side; 3) between the thumb and the index finger.
  • The circular mark of the balloon is positioned 1cm proximal to the puncture site.
  • Bands are adjusted and fixed.
  • The syringe is filled with 10 ml of air.
  • The balloon of the device is slowly inflated while the introducer is slowly withdrawn simultaneously.
  • Once the introducer is completely withdrawn, the balloon continues to be inflated until the absence of bleeding is verified.
  • Once hemostasis is achieved, the patient must be able to move his fingers and wrist without bleeding. If bleeding is observed, the balloon should be inflated to achieve adequate hemostasis.
Hemostasis after distal radial approach is done with one of two devices, one of them is designed specifically for the distal radial approach; the other is not but a modified technique with the last one could be helpful.
Other Names:
  • PreludeSYNC distal
  • Terumo Radial Band

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare the incidence of proximal radial artery occlusion assessed by ultrasound and the incidence of hematoma/bleeding assessed clinically by EASY scale of PreludeSYNC distal versus Modified Terumo Radial Band in distal radial approach.
Time Frame: 24 hours after the procedure. Patients with radial occlusion at 24 hours will be follow at 30 days.
At 24 hours after the procedure, patients will be evaluated by interrogation, physical exam and ultrasonography. The absence of Doppler flow in the proximal radial artery at wrist level will define the occlusion of the radial artery. The EASY scale will be used to classify the severity of the hematoma in degrees from I to V according to the extension.
24 hours after the procedure. Patients with radial occlusion at 24 hours will be follow at 30 days.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of distal and proximal radial artery occlusion at 24 hours after the procedure.
Time Frame: 24 hours after the procedure.
Evaluated by clinical signs and doppler.
24 hours after the procedure.
Radial arterial patency at 30 days in patients with obstruction at 24 hours.
Time Frame: 30 days after the procedure
Evaluated by clinical signs and ultrasound doppler.
30 days after the procedure
Incidence of hematoma at the approach site.
Time Frame: 24 hours after the procedure.
Evaluated by clinical signs. Classified according to EASY scale.
24 hours after the procedure.
Bleeding at the access site.
Time Frame: 24 hours after the procedure.
Evaluated by clinical signs.
24 hours after the procedure.
Neurological sequelae.
Time Frame: 24 hours after the procedure.
Evaluated by clinical signs.
24 hours after the procedure.
Incidence of radial artery pseudoaneurysms.
Time Frame: 24 hours after the procedure.
Evaluated by clinical signs and ultrasound doppler.
24 hours after the procedure.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Estimated)

November 1, 2023

Study Completion (Estimated)

December 1, 2023

Study Registration Dates

First Submitted

April 5, 2023

First Submitted That Met QC Criteria

July 27, 2023

First Posted (Actual)

July 28, 2023

Study Record Updates

Last Update Posted (Actual)

September 21, 2023

Last Update Submitted That Met QC Criteria

September 18, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 21-1255

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Intervention

Clinical Trials on Hemostatic device for distal radial approach.

3
Subscribe